BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Fluoxetine
,
rs6983267
,
FXYD4
,
calcium channel activity
,
Pseudomonas infection
,
Kidney
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
cornea verticillata
(phenotype)
Summary
General Info
Genetic Markers
Most Correlated Genes
Most Correlated SNPs
No genes found
No SNPs found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
No studies found
Explore Curated Studies Results
Literature
Most Relevant Literature
Results of the screening program for Fabry disease in patients with cornea verticillata at the Unive…
Corneal confocal microscopy in Fabry patients with cornea verticillata].
Cornea Verticillata in classical Fabry disease, first from Sri Lanka: a case report.
Cornea verticillata and acroparesthesia efficiently discriminate clusters of severity in Fabry disea…
Cornea verticillata in fabry disease.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Ophthalmic Findings During 10-year Enzyme Substitution of Danish Fabry Patients.
Non-invasive Assessment of Intraocular Pressure in MPS by Use of the Ocular Response Analyzer.
Study of the Safety and Efficacy of PRX-102 Compared to Agalsidase Beta on Renal Function
Safety and Efficacy of PRX-102 in Patients With Fabry Disease Currently Treated With REPLAGAL® (Agal…
Study of the Safety, Efficacy, & PK of Pegunigalsidase Alfa (PRX-102) 2 mg/kg IV Administered Every …
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ